AQR CAPITAL MANAGEMENT LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,527,231

+$145,143 QoQ

Shares Held

84,238

+19.2% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. DYN ranks #110 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,527,231	84,238	+19.2%	Shares	Other	2026-05-15
2025-12-31	$1,382,088	70,659	-50.2%	Shares	Other	2026-02-17
2025-09-30	$1,794,716	141,875	+230.6%	Shares	Other	2025-11-14
2025-06-30	$408,501	42,910	+82.1%	Shares	Defined	2025-08-14
2025-03-31	$246,435	23,560	-73.6%	Shares	Defined	2025-05-15
2024-09-30	$3,203,990	89,198	+950.0%	Shares	Other	2024-11-14
2024-06-30	$299,788	8,495	+4.3%	Shares	Defined	2024-08-14
2024-03-31	$231,179	8,143	-30.1%	Shares	Defined	2024-05-15
2023-09-30	$104,330	11,644	-42.3%	Shares	Defined	2023-11-14
2023-06-30	$226,901	20,169	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.